Circulating Epigenetics in Pancreatic Surgery
NCT04947696 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-07-01
Summary
The overall objective of the study is to assess DNA-methylation changes in circulating blood cells and cell free DNA in plasma from patients undergoing the Whipples procedure for pancreatic caner
Conditions
- Pancreatic Neoplasms
Interventions
- DIAGNOSTIC_TEST
-
Blood sampling
Blood sampling preoperatively and sequentially up to 30 days post op
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-30
- Primary Completion
- 2022-07-01
- Completion
- 2023-07-01
Countries
- Denmark
Study Locations
More Related Trials
-
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
NCT02790944 ·Status: COMPLETED
-
Germline Mutations in Pancreatic Adenocarcinoma
NCT03982446 ·Status: COMPLETED
-
Cohort Study of Pancreatic Cancer Risk
NCT04247503 ·Status: ACTIVE_NOT_RECRUITING
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives
NCT01210209 ·Status: COMPLETED
-
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
NCT06148298 ·Status: RECRUITING
-
A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma
NCT05947838 ·Status: RECRUITING ·Phase: NA
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer
NCT05604573 ·Status: UNKNOWN
-
Genetic Investigation of Cancer Predisposition
NCT04620278 ·Status: NOT_YET_RECRUITING
-
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
NCT05746182 ·Status: RECRUITING
-
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
NCT04576858 ·Status: UNKNOWN
-
Cell-free DNA in Hereditary And High-Risk Malignancies 1
NCT04261972 ·Status: ACTIVE_NOT_RECRUITING
-
Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection
NCT05585684 ·Status: RECRUITING
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
NCT04835675 ·Status: COMPLETED
-
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
NCT05100368 ·Status: COMPLETED
-
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
NCT00900471 ·Status: RECRUITING
-
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
NCT00899405 ·Status: RECRUITING
-
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA
NCT04104633 ·Status: COMPLETED ·Phase: NA
-
Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
NCT01831609 ·Status: UNKNOWN
-
Mapping the Human Appendix Using Single Cell Sequencing
NCT05209061 ·Status: UNKNOWN
-
CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01
NCT05871593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Epigenetic Changes in Head and Neck Cancer
NCT04260074 ·Status: COMPLETED
-
Concordance Between ctDNA Assay and FoundationOne
NCT02620527 ·Status: COMPLETED
-
CfDNA in Hereditary And High-risk Malignancies 2
NCT06726642 ·Status: RECRUITING